These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25631825)

  • 21. Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
    Meier C
    Ann Endocrinol (Paris); 2015 May; 76(2):163-4. PubMed ID: 25913524
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience.
    Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA
    Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
    Khan AA; Hanley DA; Rizzoli R; Bollerslev J; Young JE; Rejnmark L; Thakker R; D'Amour P; Paul T; Van Uum S; Shrayyef MZ; Goltzman D; Kaiser S; Cusano NE; Bouillon R; Mosekilde L; Kung AW; Rao SD; Bhadada SK; Clarke BL; Liu J; Duh Q; Lewiecki EM; Bandeira F; Eastell R; Marcocci C; Silverberg SJ; Udelsman R; Davison KS; Potts JT; Brandi ML; Bilezikian JP
    Osteoporos Int; 2017 Jan; 28(1):1-19. PubMed ID: 27613721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral.
    Kebebew E; Duh QY; Clark OH
    Arch Surg; 2003 Aug; 138(8):867-71. PubMed ID: 12912745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.
    Pyram R; Mahajan G; Gliwa A
    Maturitas; 2011 Nov; 70(3):246-55. PubMed ID: 21943558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hyperparathyroidism during pregnancy.
    Dochez V; Ducarme G
    Arch Gynecol Obstet; 2015 Feb; 291(2):259-63. PubMed ID: 25367603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
    BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.
    Duntas LH; Stathatos N
    Endocrine; 2011 Jun; 39(3):199-204. PubMed ID: 21442382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medical treatment of primary hyperparathyroidism: role of calcimimetics].
    Muñoz Torres M; García Martín A
    Endocrinol Nutr; 2009 Apr; 56 Suppl 1():29-34. PubMed ID: 19627758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hyperparathyroidism.
    Muñoz-Torres M; García-Martín A
    Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-surgical management of primary hyperparathyroidism.
    Cetani F; Saponaro F; Marcocci C
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):821-835. PubMed ID: 30665549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsurgical management of mild primary hyperparathyroidism - a reasonable option.
    Grey A
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):639-44. PubMed ID: 22803518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When would I use medical therapies for the treatment of primary hyperparathyroidism?
    Crowley RK; Gittoes NJ
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):770-3. PubMed ID: 24111629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-surgical management of primary hyperparathyroidism in the aging population.
    Cipriani C; Bilezikian JP
    Maturitas; 2020 Jun; 136():49-53. PubMed ID: 32386666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperthyroidism after surgery for primary hyperparathyroidism.
    Lindblom P; Valdemarsson S; Westerdahl J; Tennvall J; Bergenfelz A
    Langenbecks Arch Surg; 1999 Dec; 384(6):568-75. PubMed ID: 10654273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
    Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
    Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary hyperparathyroidism: management after unsuccessful parathyroid surgery.
    Silverberg SJ
    Br J Surg; 2021 Dec; 108(12):1400-1401. PubMed ID: 34738097
    [No Abstract]   [Full Text] [Related]  

  • 40. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
    Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
    Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.